PortfoliosLab logoPortfoliosLab logo
ALXO vs. OPEN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ALXO vs. OPEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALX Oncology Holdings Inc. (ALXO) and Opendoor Technologies Inc. (OPEN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ALXO vs. OPEN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ALXO
ALX Oncology Holdings Inc.
77.43%-32.34%-88.78%32.12%-47.56%-75.07%187.33%
OPEN
Opendoor Technologies Inc.
-19.73%276.52%-64.29%286.21%-92.06%-35.72%89.42%

Fundamentals

Market Cap

ALXO:

$108.84M

OPEN:

$3.59B

EPS

ALXO:

-$1.89

OPEN:

-$1.74

PB Ratio

ALXO:

4.19

OPEN:

3.57

Total Revenue (TTM)

ALXO:

$0.00

OPEN:

$4.37B

Gross Profit (TTM)

ALXO:

$0.00

OPEN:

$350.00M

EBITDA (TTM)

ALXO:

-$100.09M

OPEN:

-$287.00M

Returns By Period

In the year-to-date period, ALXO achieves a 77.43% return, which is significantly higher than OPEN's -19.73% return.


ALXO

1D
4.97%
1M
-4.98%
YTD
77.43%
6M
9.56%
1Y
221.83%
3Y*
-23.73%
5Y*
-51.43%
10Y*

OPEN

1D
5.64%
1M
-13.65%
YTD
-19.73%
6M
-39.32%
1Y
374.12%
3Y*
40.06%
5Y*
-25.97%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALXO vs. OPEN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALXO
ALXO Risk / Return Rank: 8888
Overall Rank
ALXO Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
ALXO Sortino Ratio Rank: 9090
Sortino Ratio Rank
ALXO Omega Ratio Rank: 8383
Omega Ratio Rank
ALXO Calmar Ratio Rank: 9191
Calmar Ratio Rank
ALXO Martin Ratio Rank: 8686
Martin Ratio Rank

OPEN
OPEN Risk / Return Rank: 9292
Overall Rank
OPEN Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
OPEN Sortino Ratio Rank: 9595
Sortino Ratio Rank
OPEN Omega Ratio Rank: 9191
Omega Ratio Rank
OPEN Calmar Ratio Rank: 9595
Calmar Ratio Rank
OPEN Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALXO vs. OPEN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ALX Oncology Holdings Inc. (ALXO) and Opendoor Technologies Inc. (OPEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALXOOPENDifference

Sharpe ratio

Return per unit of total volatility

1.89

2.28

-0.38

Sortino ratio

Return per unit of downside risk

2.86

3.46

-0.60

Omega ratio

Gain probability vs. loss probability

1.31

1.40

-0.09

Calmar ratio

Return relative to maximum drawdown

4.08

5.71

-1.62

Martin ratio

Return relative to average drawdown

8.57

9.41

-0.84

ALXO vs. OPEN - Sharpe Ratio Comparison

The current ALXO Sharpe Ratio is 1.89, which is comparable to the OPEN Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of ALXO and OPEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ALXOOPENDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.89

2.28

-0.38

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.52

-0.23

-0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.38

-0.12

-0.27

Correlation

The correlation between ALXO and OPEN is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ALXO vs. OPEN - Dividend Comparison

Neither ALXO nor OPEN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALXO vs. OPEN - Drawdown Comparison

The maximum ALXO drawdown since its inception was -99.64%, roughly equal to the maximum OPEN drawdown of -98.57%. Use the drawdown chart below to compare losses from any high point for ALXO and OPEN.


Loading graphics...

Drawdown Indicators


ALXOOPENDifference

Max Drawdown

Largest peak-to-trough decline

-99.64%

-98.57%

-1.07%

Max Drawdown (1Y)

Largest decline over 1 year

-50.46%

-57.47%

+7.01%

Max Drawdown (5Y)

Largest decline over 5 years

-99.50%

-97.93%

-1.57%

Current Drawdown

Current decline from peak

-98.21%

-86.52%

-11.69%

Average Drawdown

Average peak-to-trough decline

-78.54%

-74.23%

-4.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.03%

34.84%

-10.81%

Volatility

ALXO vs. OPEN - Volatility Comparison

The current volatility for ALX Oncology Holdings Inc. (ALXO) is 18.66%, while Opendoor Technologies Inc. (OPEN) has a volatility of 21.42%. This indicates that ALXO experiences smaller price fluctuations and is considered to be less risky than OPEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ALXOOPENDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.66%

21.42%

-2.76%

Volatility (6M)

Calculated over the trailing 6-month period

73.93%

64.21%

+9.72%

Volatility (1Y)

Calculated over the trailing 1-year period

118.14%

165.92%

-47.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

99.42%

113.89%

-14.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

99.22%

111.60%

-12.38%

Financials

ALXO vs. OPEN - Financials Comparison

This section allows you to compare key financial metrics between ALX Oncology Holdings Inc. and Opendoor Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
736.00M
(ALXO) Total Revenue
(OPEN) Total Revenue
Values in USD except per share items